Radiopharm Theranostics【RAD】銘柄情報

Radiopharm Theranostics Limited (RAD) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.02

( 5.26% )

買値

0.02

売値

0.021

出来高

4,679,285

0.019 日の範囲 0.0205

0.017 52 週間の範囲 0.04

時価総額

70.884M

前日終値

0.019

始値

0.02

時刻

200000

0.02

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 2,733,824

発行済株式数

3,544,216,160

配当利回り

PER

-1.05

1 株当たり利益 (EPS)

-0.02

歳入

16.28M

純利益

-46.58M

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.radiopharmtheranostics.com

本社

Carlton, Australia

設立

2026

Radiopharm Theranostics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker RAD. The last closing price for Radiopharm Theranostics was AUD0.02. Over the last year, Radiopharm Theranostics shares have traded in a share price range of AUD 0.017 to AUD 0.04.

Radiopharm Theranostics currently has 3,544,216,160 shares in issue. The market capitalisation of Radiopharm Theranostics is AUD70.88 million. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -1.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.02	0.021	0.019	1883727	0.0199163	DE
4	0.0005	2.5641025641	0.0195	0.022	0.018	1936725	0.02005948	DE
12	-0.002	-9.09090909091	0.022	0.024	0.018	2626784	0.02033759	DE
26	-0.002	-9.09090909091	0.022	0.037	0.017	6470161	0.0246079	DE
52	-0.007	-25.9259259259	0.027	0.04	0.017	5485745	0.02555819	DE
156	-0.115	-85.1851851852	0.135	0.155	0.017	3894787	0.02938402	DE
260	-0.45	-95.7446808511	0.47	0.495	0.017	2814994	0.04561796	DE